Development and optimization by factorial design of polymeric nanoparticles for simvastatin delivery
Dalila Pinto Malaquias; Lays Fernanda Nunes Dourado; Ângela Maria Quintão Lana; Fernando Souza; José Vilela; Margareth Andrade; Juan Pedro Bretas Roa; Álvaro Dutra de Carvalho-Junior; Elaine Amaral Leite
Abstract
Keywords
References
1 Endo, A. (2010). A historical perspective on the discovery of statins.
2 Liu, Y. S., Ou, M. E., Liu, H., Gu, M., Lv, L. W., Fan, C., Chen, T., Zhao, X. H., Jin, C. Y., Zhang, X., Ding, Y., & Zhou, Y. S. (2014). The effect of simvastatin on chemotactic capability of SDF-1α and the promotion of bone regeneration.
3 Yue, X., Niu, M., Zhang, T., Wang, C., Wang, Z., Wu, W., Zhang, Q., Lai, C., & Zhou, L. (2016).
4 Liu, X., Li, X., Zhou, L., Li, S., Sun, J., Wang, Z., Gao, Y., Jiang, Y., Lu, H., Wang, Q., & Dai, J. (2013). Effects of simvastatin-loaded polymeric micelles on human osteoblast-like MG-63 cells.
5 Basniwal, P. K., & Jain, D. (2012). Simvastatin: review of updates on recent trends in pharmacokinetics, pharmacodynamics, drug-drug interaction, impurities and analytical methods.
6 Yin, H., Shi, Z.-G., Yu, Y.-S., Hu, J., Wang, R., Luan, Z.-P., & Guo, D.-H. (2012). Protection against osteoporosis by statins is linked to a reduction of oxidative stress and restoration of nitric oxide formation in aged and ovariectomized rats.
7 Lindenberg, M., Kopp, S., & Dressman, J. B. (2004). Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system.
8 Jiang, T., Han, N., Zhao, B., Xie, Y., & Wang, S. (2012). Enhanced dissolution rate and oral bioavailability of simvastatin nanocrystal prepared by sonoprecipitation.
9 García, M. J., Reinoso, R. F., Sánchez Navarro, A., & Prous, J. R. (2003). Clinical pharmacokinetics of statins.
10 Paulraj, P., Vnootheni, N., Chandramohan, M., & Thevarkattil, M. J. P. (2018). Exploration of Global Trend on Biomedical Application of Polyhydroxyalkanoate (PHA): a patent survey.
11 Bokrova, J., Marova, I., Matouskova, P., & Pavelkova, R. (2019). Fabrication of novel PHB-liposome nanoparticles and study of their toxicity in vitro.
12 Bidone, J., Melo, A. P. P., Bazzo, G. C., Carmignan, F., Soldi, M. S., Pires, A. T. N., & Lemos-Senna, E. (2009). Preparation and characterization of ibuprofen-loaded microspheres consisting of poly(3-hydroxybutyrate) and methoxy poly (ethylene glycol)-b-poly (D,L-lactide) blends or poly(3-hydroxybutyrate) and gelatin composites for controlled drug release.
13 Bugnicourt, E., Cinelli, P., Lazzeri, A., & Alvarez, V. (2014). Polyhydroxyalkanoate (PHA): review of synthesis, characteristics, processing and potential applications in packaging.
14 Roa, J. P. B., Mano, V., Faustino, P. B., Felix, E. B., Silva, M. E. S. R., & Souza Filho, J. D. (2010). Síntese e Caracterização do Copolímero Poli(3 Hidroxibutirato co ε Caprolactona) a Partir de Poli(3 Hidroxibutirato) e Poli(ε Caprolactona).
15 Gassner, F., & Owen, A. J. (1994). Physical properties of poly(β-hydroxybutyrate)-poly(ε-caprolactone) blends.
16 Huang, M.-H., Li, S., Hutmacher, D. W., Coudane, J., & Vert, M. (2006). Degradation characteristics of poly(ε-caprolactone)-based copolymers and blends.
17 Lovera, D., Márquez, L., Balsamo, V., Taddei, A., Castelli, C., & Müller, A. J. (2007). Crystallization, morphology, and enzymatic degradation of polyhydroxybutyrate/ polycaprolactone (PHB/PCL) blends.
18 Chee, M. J. K., Ismail, J., Kummerlöwe, C., & Kammer, H. W. (2002). Study on miscibility of PEO and PCL in blends with PHB by solution viscometry.
19 Suave, J., Dall’Agnol, E. C., Pezzin, A. P. T., Meier, M. M., & Silva, D. A. K. (2010). Biodegradable microspheres of poly(3-hydroxybutyrate)/poly(ε-caprolactone) loaded with malathion pesticide: Preparation, characterization, and
20 Huang, J., Wigent, R. J., & Schwartz, J. B. (2006). Nifedipine molecular dispersion in microparticles of ammonio methacrylate copolymer and ethylcellulose binary blends for controlled drug delivery: effect of matrix composition.
21 Oliveira, M. A., Yoshida, M. I., Gomes, E. C. L., Mussel, W. N., Vianna-Soares, C. D., & Pianetti, G. A. (2010). Análise térmica aplicada à caracterização da sinvastatina em formulações farmacêuticas.
22 Zhang, Y., Zhang, J., Jiang, T., & Wang, S. (2011). Inclusion of the poorly water-soluble drug simvastatin in mesocellular foam nanoparticles: drug loading and release properties.
23 Kouhi, M., Morshed, M., Varshosaz, J., & Fathi, M. H. (2013). Poly (ε-caprolactone) incorporated bioactive glass nanoparticles and simvastatin nanocomposite nanofibers: Preparation, characterization and
24 Liechty, W. B., Kryscio, D. R., Slaughter, B. V., & Peppas, N. A. (2010). Polymers for drug delivery systems.
25 Farrag, Y., Montero, B., Rico, M., Barral, L., & Bouza, R. (2018). Preparation and characterization of nano and micro particles of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) via emulsification/solvent evaporation and nanoprecipitation techniques.
26 Makadia, H. K., & Siegel, S. J. (2011). Poly Lactic-co-Glycolic Acid (PLGA) as biodegradable controlled drug delivery carrier.
27 Deng, C., Jiang, Y., Cheng, R., Meng, F., & Zhong, Z. (2012). Biodegradable polymeric micelles for targeted and controlled anticancer drug delivery: promises, progress and prospects.
28 Kumari, A., Yadav, S. K., & Yadav, S. C. (2010). Biodegradable polymeric nanoparticles based drug delivery systems.
29 Yu, L., Dean, K., & Li, L. (2006). Polymer blends and composites from renewable resources.
30 Enrrico, C., Bartoli, C., Chiellini, F., & Chiellini, E. (2009). Poly(hydroxyalkanoates)-based polymeric nanoparticles for drug delivery.
31 Shakeri, F., Shakeri, S., & Hojjatoleslami, M. (2014). Preparation and characterization of carvacrol loaded polyhydroxybutyrate nanoparticles by nanoprecipitation and dialysis methods.
32 Kim, B. O., & Woo, S. I. (1998). Compatibilizing capability of poly(β-hydroxybutyrate-co-ε-caprolactone) in the blend of poly(β-hydroxybutyrate) and poly(ε-caprolactone).
33 Leimann, F. V., Cardozo Filho, L., Sayer, C., & Araújo, P. H. H. (2013). Poly(3-hydroxybutyrate-co-3- hydroxyvalerate) nanoparticles prepared by a miniemulsion/solvent evaporation technique: effect of phbv molar mass and concentration.
34 Musyanovych, A., Schmitz-Wienke, J., Mailänder, V., Walther, P., & Landfester, K. (2008). Preparation of Biodegradable Polymer Nanoparticles by Miniemulsion Technique and Their Cell Interactions.
35 Dourado, L. F. N., Pierucci, A., Roa, J. P. B., & Carvalho Júnior, Á. D. (2021). Assessment of implantable drug delivery technology: poly (3-hydroxybutyrate) / polypropylene glycol films containing simvastatin.
36 Terukina, T., Naito, Y., Tagami, T., Morikawa, Y., Henmi, Y., Prananingrum, W., Ichikawa, T., & Ozeki, T. (2016). The effect of the release behavior of simvastatin from different PLGA particles on bone regeneration
37 Sinha, V. R., Bansal, K., Kaushik, R., Kumria, R., & Trehan, A. (2004). Poly-ε-caprolactone microspheres and nanospheres: an overview.
38 Souto, E. B., Severino, P., & Santana, M. H. A. (2012). Preparação de nanopartículas poliméricas a partir de polímeros pré-formados: parte II.
39 Montasser, I., Fessi, H., & Coleman, A. W. (2002). Atomic force microscopy imaging of novel type of polymeric colloidal nanostructures.
40 Auras, R. A., Harte, B., Selke, S., & Hernandez, R. (2003). Mechanical, physical, and barrier properties of poly(lactide) films.
41 Ding, Y., Roether, J. A., Boccaccini, A. R., & Schubert, D. W. (2014). Fabrication of electrospun poly (3-hydroxybutyrate)/poly (ε-caprolactone)/silica hybrid fibermats with and without calcium addition.
42 Calvo, P., Vila-Jato, J. L., & Alonso, M. J. (1996). Comparative in vitro evaluation of several colloidal systems, nanoparticles, nanocapsules, and nanoemulsions, as ocular drug carriers.
43 D’Souza, S. S., & DeLuca, P. P. (2005). Development of a dialysis in vitro release method for biodegradable microspheres.
44 Schaffazick, S. R., Guterres, S. S., Freitas, L. L., & Pohlmann, A. R. (2003). Caracterização e estabilidade físico-química de sistemas poliméricos nanoparticulados para administração de fármacos.
45 Dash, T. K., & Konkimalla, V. B. (2012).
46 Schaefer, M. J., & Singh, J. (2002). Effect of tricaprin on the physical characteristics and in vitro release of etoposide from PLGA microspheres.
47 Wischke, C., & Schwendeman, S. P. (2008). Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles.
48 Schaffazick, S. R., Pohlmann, A. R., Freitas, L. L., & Guterres, S. S. (2002). Caracterização e estudo de estabilidade de suspensões de nanocápsulas e de nanoesferas poliméricas contendo diclofenaco.
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email